CANCER
IMMUNOTHERAPY
On October 17, 2016, former Vice President Joe Biden launched the National Cancer Moonshot which featured immunotherapy as a centerpiece.
DID YOU KNOW?
When, Where, & How: Cancer Discovery
-
The disease of cancer can be traced back to Egypt about 1500 B.C. in mummies. According to inscriptions, surface tumors were surgically removed in a similar way they are removed today.
-
For 1,400 years in Ancient Greece, many believed Hippocrates in his theory that an excess of black bile caused cancer. In Ancient Egypt
What is immunotherapy?
-
Immunotherapy is the use of therapeutic antibodies, molecules, or vaccines as a drug to activate a person's immunity.
-
Antibodies circulate throughout the body until they find and attach to antigens. Other parts in the immune system can destroy cells containing antigens.
-
Laboratory produced molecules called Monoclonal antibodies are made to mimick.
-
Immunotherapy can be done on its own or with other cancer treatments.
Immunotherapy Explained
How does it work?
-
Antibodies in the immune system find and attach themselves to antigens. They will then alert other disease-fighting cells.
-
Immune system is stimulated to work harder to attack cancer cells (foreign invaders) or giving the body man-made immune system proteins.
-
Researchers came up with different types of immunotherapy which are: monoclonal antibodies, immune checkpoint inhibitors, cancer vaccines, and other non-specific immunotherapies.
-
In some instances, the treatment may not be effective due to the patient's age, health, and type of cancer.
Why is it effective?
-
New studies has found immunotherapy to me more effective than chemotherapy.
-
Shown to have effectiveness in a wider population of people.
-
Patients with low level of PD-L1 in their tumors showed effectiveness towards immunotherapy.
-
Contains fewer side effects for the patient.
-
Help patient stay cancer free for a longer period of time.
-
Responds better to cancers that can't handle radiation or chemotherapy.
The Path to a Cancer Cure
Market Research Future has a half cooked research report on the global cancer immunotherapy market. Global Cancer Immunotherapy Market is Expecting a Huge Market Growth During 2017-2023 at CAGR of 14.8% Due to Advantages of Immunotherapy Over Other Therapy...
February 16, 2018
Worldwide Cancer Immunotherapy Market is expected to grow at a healthy CAGR of 14.8% and reach till USD 101.6 billion by 2023
Combination Immunotherapy: Landmark Study Confirms Success
Studies continue to demonstrate the success of immunotherapy, a type of treatment that boosts the immune system’s inherent ability to defend against cancer. Memorial Sloan Kettering researchers have played an important role in the development of nivolumab and ipilimumab, drugs that unleash immune cells...